Please assess the completion status of the following clinical trial:

Trial Title: Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years old or older~* currently be treated at a University of MS Medical Center Internal Medicine Clinics~* currently taking metoprolol succinate for hypertension~* have their hypertension controlled (\<140/90).~Exclusion Criteria:~* uncontrolled hypertension~* severe renal or moderate hepatic impairment~* currently taking CYP 2D6 inducers/inhibitors~* recent stroke (less than 6 months)~* recent myocardial infarction (less than 6 months)~* congestive heart failure~* diagnosed obstructive sleep apnea~* atrial fibrillation~* arm circumference \>50 cm

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Metoprolol to nebivolol (Type: EXPERIMENTAL): metoprolol 25-200mg at a stable daily dose for 4 weeks, then change to nebivolol at a comparable stable dose (5-20 mg) for 4 -5 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).